Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613001049763
Ethics application status
Approved
Date submitted
11/09/2013
Date registered
20/09/2013
Date last updated
20/09/2013
Type of registration
Retrospectively registered

Titles & IDs
Public title
To excise or ablate endometriosis? A prospective randomized double blinded trial with 5 years follow-up.
Scientific title
Prospective randomized double blinded controlled trial comparing treatment of endometriosis with excision versus ablation on pain, rates of pregnancy, repeat surgery and use of hormonal medication in the 5 years post-operation.
Secondary ID [1] 283188 0
nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Endometriosis 290049 0
Condition category
Condition code
Surgery 290425 290425 0 0
Surgical techniques
Reproductive Health and Childbirth 290494 290494 0 0
Other reproductive health and childbirth disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Interventions - Excision of endometriosis. To excise the endometriosis, spade with monopolar current or scissors are used to cut out the endometriosis. Duration of the procedure depends on the amount of endometriosis present and expertise of the surgeon.
Intervention code [1] 287914 0
Treatment: Surgery
Comparator / control treatment
Comparator - ablation of endometriosis. Monopolar or bipolar diathermy is used to ablate and burn the endometriosis. Duration of the ablation on the endometriosis is determined by the surgeon. The duration of the total procedure depends on the amount of endometriosis present.
Control group
Active

Outcomes
Primary outcome [1] 290451 0
Change in pain VAS scores during 5 years post-operation
Timepoint [1] 290451 0
5 years post operation
Secondary outcome [1] 304543 0
Rates of pregnancy.
Timepoint [1] 304543 0
5 years post-operation. Assessed via post operative questionnaires.
Secondary outcome [2] 304700 0
Repeat Surgery
Timepoint [2] 304700 0
5 years post operation. Assessed via post operative questionnaires.
Secondary outcome [3] 304701 0
Hormonal medication
Timepoint [3] 304701 0
5 years post operation. Assessed via post operative questionnaires.

Eligibility
Key inclusion criteria
Women booked to have a laparoscopy to manage pain symptoms suggestive of endometriosis, over 18 years, speak English, not be using or planning to use continuous hormonal medications and give consent to the trial.
Minimum age
18 Years
Maximum age
50 Years
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
Under 18 years and over 50 years.
Do not speak English.
Do not consent.
Use or planning to use continuous hormonal medications.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Subjects are enrolled in pre-admission clinic.
During laparoscopy, if endometriosis is visually diagnosed and it does not involve bowel, bladder or ureter muscularis, then treatment is randomised to excision or ablation using computer generated randomisation in numbered, sealed, opaque envelops.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer generated random sequence placed in numbered opaque sealed envelops.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
The power calculation assumed a base reduction in overall pain VAS score of 3.7 (estimated from the reduction in mean VAS pain score at 6 months in Sutton’s study in 1994 [Sutton et al. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril 1994;62:696–700]); a clinically significant difference between groups being a change of VAS score of 1.0; an SD of 2.0; and a power of 80% and alpha value of 5%. The calculated sample size was N = 49 in each group. To allow for wastage a sample size of 120 (60 in each group) was initially chosen. However, an interim analysis demonstrated a subject loss of 35% at 1 year, the sample size was then increased to 180 to compensate.

Proportions were compared with Chi-squared testing. Continuous variables were compared using the t-test for independent variables and Welch’s t-test if the assumption of equal variance was not met. Medians were used to describe rAFS scores and comparison was with the Mann-Whitney U test. Where potential confounding factors were present (defined when p<0.25) multivariate linear regression analysis was performed with backward removal of variables. Survivor analysis (log rank test statistic) was used for comparing dichotomous events over time such as pregnancy and further treatments (medical and surgical). Repeated measures of continuous variables were analyzed using one way analysis of variance (ANOVA) with Tamhane’s T2 post-hoc test where equal variance was not assumed. Differences were considered significant if p<0.05.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/07/2001
Actual
2/07/2001
Date of last participant enrolment
Anticipated
28/09/2007
Actual
28/09/2007
Date of last data collection
Anticipated
Actual
Sample size
Target
180
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment postcode(s) [1] 7341 0
3052 - Parkville

Funding & Sponsors
Funding source category [1] 287933 0
Charities/Societies/Foundations
Name [1] 287933 0
Australian Gynaecological Endoscopy Society Research Foundation
Country [1] 287933 0
Australia
Funding source category [2] 287934 0
Charities/Societies/Foundations
Name [2] 287934 0
L.E.W. Carty Charitable Fund
Country [2] 287934 0
Australia
Funding source category [3] 287935 0
Charities/Societies/Foundations
Name [3] 287935 0
Royal Women's Hospital Foundation
Country [3] 287935 0
Australia
Primary sponsor type
Individual
Name
A/Prof Martin Healey
Address
Royal Women's Hospital
20 Flemington Road
Parkville VIC 3052
Country
Australia
Secondary sponsor category [1] 286657 0
Individual
Name [1] 286657 0
Dr Claudia Cheng
Address [1] 286657 0
Royal Women's Hospital
20 Flemington Road
Parkville VIC 3052
Country [1] 286657 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 289862 0
Research and Ethics Committees of the Royal Women’s Hospital
Ethics committee address [1] 289862 0
Ethics committee country [1] 289862 0
Australia
Date submitted for ethics approval [1] 289862 0
19/05/1998
Approval date [1] 289862 0
14/10/1998
Ethics approval number [1] 289862 0
Project 98/12

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 42818 0
A/Prof Martin Healey
Address 42818 0
Royal Women's Hospital, Melbourne, Victoria, Australia and Department Obstetrics & Gyneacology, University of Melbourne, Victoria, Australia

20 Flemington Road. Parkville. Victoria. 3052
Country 42818 0
Australia
Phone 42818 0
+61 3 9425 9833
Fax 42818 0
Email 42818 0
mghealey@optusnet.com.au
Contact person for public queries
Name 42819 0
Martin Healey
Address 42819 0
Royal Women's Hospital, Melbourne, Victoria, Australia and Department Obstetrics & Gyneacology, University of Melbourne, Victoria, Australia

20 Flemington Road. Parkville. Victoria. 3052
Country 42819 0
Australia
Phone 42819 0
+61 3 9425 9833
Fax 42819 0
Email 42819 0
mghealey@optusnet.com.au
Contact person for scientific queries
Name 42820 0
Martin Healey
Address 42820 0
Royal Women's Hospital, Melbourne, Victoria, Australia and Department Obstetrics & Gyneacology, University of Melbourne, Victoria, Australia

20 Flemington Road. Parkville. Victoria. 3052
Country 42820 0
Australia
Phone 42820 0
+61 3 9425 9833
Fax 42820 0
Email 42820 0
mghealey@optusnet.com.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.